The cardiovascular health of young people with severe mental illness: Addressing an epidemic within an epidemic

Psychiatrist

Volumn 36, Issue 10, 2012, Pages 375-378

  Bailey, Sue ^a,b   Gerada, Clare ^c   Lester, Helen ^d   Shiers, David ^e  

^a GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c Hurley Clinic   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e National Mental Health Development Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID;

ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; FAMILY HISTORY; GLUCOSE INTOLERANCE; HEALTH PROMOTION; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREMATURE MORTALITY; PSYCHIATRIC TREATMENT; PSYCHOSIS; SEDENTARY LIFESTYLE; WEIGHT GAIN;

EID: 84867670653     PISSN: 17583209     EISSN: 17583217     Source Type: Journal    
DOI: 10.1192/pb.bp.112.039727     Document Type: Article

References (41)

1. HM Government. No Health without Mental Health: Delivering Better Mental Health Outcomes for People of All Ages. Department of Health, 2011.
2. Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 2011; 199: 441-2.
3. McCreadie RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Descriptive study. Br J Psychiatry 2003; 183: 534-9. (Pubitemid 37533200)
4. Newcomer J, Hennekens JH. Severe mental illness and risk of cardiovascular disease. JAMA 2007; 298: 1794-6. (Pubitemid 47598448)
5. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31-41.
6. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. No mental health without physical health. Lancet 2011; 377: 611.
7. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-31. (Pubitemid 47529346)
8. Manderbacka K, Arffman M, Sund R, Haukka J, Keskimäki I,Wahlbeck K. How does a history of psychiatric hospital care influence access to coronary care: a cohort study. BMJ Open 2012; 2: e000831.
9. Mitchell AJ, Malone D, Doebbeling CC. Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies. Br J Psychiatry 2009; 194: 491-9.
10. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose and elevation of cortisol in drug-naïve first-episode schizophrenia. Am J Psychiatry 2003; 160: 284-9. (Pubitemid 41110453)
11. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009; 302: 1765-73.
12. Foley D, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011; 68: 609-16.
13. Curtis J, Henry C,Watkins A, Newall H, Samaras K,Ward P. Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study. Early Interv Psychiatry 2011; 5: 108-14.
14. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001; 46: 273-81. (Pubitemid 32423994)
15. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74. (Pubitemid 38702847)
16. Baker JL, Olsen LW, Sørensen TI. Childhood bodymass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-37. (Pubitemid 350223387)
17. Kahn RS, FleischhackerWW, Boter H, Davidson M,Vergouwe Y, Keet IP, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2007; 371: 1085-97. (Pubitemid 351418005)
18. Nasrallah HA. Folie en masse! It's so tempting to drink the Kool-Aid. Curr Psychiatry 2011; 10: 3.
19. Alvarez-Jimenez M, Gonzalez-Blanch C, Crespo-Facorro B, Hetrick SE, Rodríguez-Sánchez JM, Pérez-Iglesias R, et al. Antipsychotic-induced weight gain in chronic and first episode psychotic disorders - a systematic critical reappraisal. CNS Drugs 2008; 22: 547-62. (Pubitemid 351822117)
20. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23. (Pubitemid 41345943)
21. Vancampfort D, Probst M, Sweers K, Maurissen K, Knapen J, De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand 2011; 123: 423-30.
22. Fedorowicz VJ, Fombonne E. Metabolic side effects of atypical antipsychotics in children: a literature review. J Psychopharmacol 2005; 19: 533-50. (Pubitemid 41392308)
23. Hack S, Chow B. Paediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Adolesc Psychopharmacol 2001; 11: 59-67. (Pubitemid 32295184)
24. Yates T, Davies MJ, Khunti K. Obesity and chronic disease in younger people: an unfolding crisis. Br J Gen Pract 2012; 62: 4-5.
25. Joint Health Surveys Unit of the National Centre for Social Research, Department of Epidemiology and Public Health University College London Medical School. Health Survey for England -2009: Health and Lifestyles. NSH Information Centre, 2010 (http://www.ic.nhs.uk/pubs/hse09report).
26. Wilmot EG, Davies MJ, Yates T, Benhalima K, Lawrence IG, Khunti K. Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad Med J 2010; 86: 711-8.
27. Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diab Care 2003; 26: 2999-3005. (Pubitemid 37345170)
28. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981; 282: 1847-51. (Pubitemid 11047749)
29. NHS Employers, British Medical Association. Quality and Outcomes Framework Guidance for GMS Contract 2011/12: Delivering Investment in General Practice. NHS Employers, 2011 (http://www.nhsemployers.org/ SiteCollectionDocuments/QOFguidanceGMScontract-2011-12-FL%2013042011.pdf).
30. Curtis J, Newall H, Samaras K. The heart of the matter: cardiometabolic care in youth with psychosis. Early Interv Psychiatry 2012; 6: 347-53.
31. Álvarez-Jiménez M, Hetrick SE, González-Blanch C, Gleeson JF, McGorry PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008; 193: 101-7.
32. El-Mallakh P. Doing my best: poverty and self-care among individuals with schizophrenia and diabetes mellitus. Arch Psychiatr Nurs 2007; 21: 49-60.
33. Cimo A, Stergiopoulos E, Cheng C, Bonato S, Dewa C. Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review. BMC Psychiatry 2012; 12: 24.
34. Holt RI, Abdelrahman T, Hirsch M, Dhesi Z, George T, Blincoe T, et al. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol 2010; 24: 867-73.
35. Weiden PJ. Switching antipsychotic medications: not enough, too often, or just right? Am J Psychiatry 2011; 168: 9.
36. Morrison AP, Hutton P, Shiers D, Turkington D. Antipsychotics: is it time to introduce patient choice? Br J Psychiatry 2012; 201: 83-4.
37. Morrison AP, Hutton P,Wardle M, Spencer H, Barratt S, Brabban A, et al. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial. Psychol Med 2012; 42: 1049-56.
38. Fulford KW. Bringing together values-based and evidence-based medicine: UK Department of Health initiatives in the 'personalization' of care. J Eval Clin Pract 2011; 17: 341-3.
39. Newall H, Myles N, Ward P, Samaras K, Shiers D, Curtis J. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Int Clin Psychopharmacol 2012; 27: 69-75.
40. National Institute for Health and Clinical Excellence. Preventing Type 2 Diabetes - Risk Identification and Interventions for Individuals at High Risk. NICE, 2012.
41. Lester H, Shiers DE, Rafi I, Cooper SJ, Holt RIG. Positive Cardiometabolic Health Resource: An Intervention Framework for Patients with Psychosis on Antipsychotic Medication. Royal College of Psychiatrists Centre for Quality Improvement, 2012, in press.